TY - JOUR
T1 - Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population
AU - Yi, Sofia
AU - Rathod, Rutu A.
AU - Natchimuthu, Vijaya Subbu
AU - Bhalla, Sheena
AU - Lee, Jessica L.
AU - Browning, Travis
AU - Adesina, Joyce O.
AU - Do, Minh
AU - Balis, David
AU - Wiliams, Juana Gamarra de
AU - Kitchell, Ellen
AU - Santini, Noel O.
AU - Johnson, David H.
AU - Hamann, Heidi A.
AU - Craddock Lee, Simon J.
AU - Hughes, Amy E.
AU - Gerber, David E.
N1 - Publisher Copyright:
© JNCCN—Journal of the National Comprehensive Cancer Network.
PY - 2024/7
Y1 - 2024/7
N2 - Background: Recent modifications to low-dose CT (LDCT)–based lung cancer screening guidelines increase the number of eligible individuals, particularly among racial and ethnic minorities. Because these populations disproportionately live in metropolitan areas, we analyzed the association between travel time and initial LDCT completion within an integrated, urban safety-net health care system. Methods: Using Esri’s StreetMap Premium, OpenStreetMap, and the r5r package in R, we determined projected private vehicle and public transportation travel times between patient residence and the screening facility for LDCT ordered in March 2017 through December 2022 at Parkland Memorial Hospital in Dallas, Texas. We characterized associations between travel time and LDCT completion in univariable and multivariable analyses. We tested these associations in a simulation of 10,000 permutations of private vehicle and public transportation distribution. Results: A total of 2,287 patients were included in the analysis, of whom 1,553 (68%) completed the initial ordered LDCT. Mean age was 63 years, and 73% were underrepresented minorities. Median travel time from patient residence to the LDCT screening facility was 17 minutes by private vehicle and 67 minutes by public transportation. There was a small difference in travel time to the LDCT screening facility by public transportation for patients who completed LDCT versus those who did not (67 vs 66 min, respectively; P 5.04) but no difference in travel time by private vehicle for these patients (17 min for both; P 5.67). In multivariable analysis, LDCT completion was not associated with projected travel time to the LDCT facility by private vehicle (odds ratio, 1.01; 95% CI, 0.82–1.25) or public transportation (odds ratio, 1.14; 95% CI, 0.89–1.44). Similar results were noted across travel-type permutations. Black individuals were 29% less likely to complete LDCT screening compared with White individuals. Conclusions: In an urban population comprising predominantly underrepresented minorities, projected travel time is not associated with initial LDCT completion in an integrated health care system. Other reasons for differences in LDCT completion warrant investigation.
AB - Background: Recent modifications to low-dose CT (LDCT)–based lung cancer screening guidelines increase the number of eligible individuals, particularly among racial and ethnic minorities. Because these populations disproportionately live in metropolitan areas, we analyzed the association between travel time and initial LDCT completion within an integrated, urban safety-net health care system. Methods: Using Esri’s StreetMap Premium, OpenStreetMap, and the r5r package in R, we determined projected private vehicle and public transportation travel times between patient residence and the screening facility for LDCT ordered in March 2017 through December 2022 at Parkland Memorial Hospital in Dallas, Texas. We characterized associations between travel time and LDCT completion in univariable and multivariable analyses. We tested these associations in a simulation of 10,000 permutations of private vehicle and public transportation distribution. Results: A total of 2,287 patients were included in the analysis, of whom 1,553 (68%) completed the initial ordered LDCT. Mean age was 63 years, and 73% were underrepresented minorities. Median travel time from patient residence to the LDCT screening facility was 17 minutes by private vehicle and 67 minutes by public transportation. There was a small difference in travel time to the LDCT screening facility by public transportation for patients who completed LDCT versus those who did not (67 vs 66 min, respectively; P 5.04) but no difference in travel time by private vehicle for these patients (17 min for both; P 5.67). In multivariable analysis, LDCT completion was not associated with projected travel time to the LDCT facility by private vehicle (odds ratio, 1.01; 95% CI, 0.82–1.25) or public transportation (odds ratio, 1.14; 95% CI, 0.89–1.44). Similar results were noted across travel-type permutations. Black individuals were 29% less likely to complete LDCT screening compared with White individuals. Conclusions: In an urban population comprising predominantly underrepresented minorities, projected travel time is not associated with initial LDCT completion in an integrated health care system. Other reasons for differences in LDCT completion warrant investigation.
UR - http://www.scopus.com/inward/record.url?scp=85199223172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85199223172&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2023.7112
DO - 10.6004/jnccn.2023.7112
M3 - Article
C2 - 38670152
AN - SCOPUS:85199223172
SN - 1540-1405
VL - 22
SP - 308
EP - 314
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 5
ER -